Product Description

Reditux 100 mg Injection is a biosimilar rituximab formulation produced by Dr. Reddy’s Laboratories. It is primarily used to treat non-Hodgkin lymphoma (NHL), chronic lymphocytic leukemia (CLL), rheumatoid arthritis (RA), and vasculitis disorders like granulomatosis with polyangiitis and microscopic polyangiitis. The medicine targets the CD20 protein found on B-cells and works by destroying these cells, thereby reducing abnormal immune activity or cancer cell proliferation. Reditux 100 mg is often used when lower dosages or body surface area–based calculations apply, especially in pediatric or lighter adult patients. Macarius Health ensures timely access to cold-chain compliant Reditux 100 mg vials with full regulatory and logistic support across India.